EUCTR2009-011534-10-SE进行中（未招募）不适用
Effects on insulin sensitivity and body composition of combination therapy with growth hormone (GH) and insulin-like growth factor-I (IGF-I) in growth hormone deficient adults with impaired glucose tolerance or diabetes - GH-IGF-I
Karolinska University Hospital0 个研究点开始时间: 2009年4月24日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Subjects who meet all of the following criteria are eligible for this trial:
- •Verified profound GH deficiency
- •Impaired glucose tolerance test or diabetes (stable on antidiabetic medication)
- •Age 18-70 years
- •Each patient must sign an informed consent document before inclusion in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects meeting one or more of the following criteria cannot be selected:
- •Known or suspected allergy to GH or IGF-I preparation
- •GH treatment within the last year
- •Insulin treatment
- •Diabetes with HbA1C>9%
- •Malignancy or other serious diseases (ex severe cardiovascular diseases, severe infections)
- •Increased liver enzymes (ASAT or ALAT>2.5 normal range)
研究者
相似试验
已完成
不适用
Impact on body composition and Sugar metabolism and Lipid metabolism by Diet therapy of BCAA or EPA added diet to patients with obesity type 2 diabetesobesity type 2 diabetesJPRN-UMIN000023441The University of Tokyo Hospital20
已完成
4 期
Impact on insulin sensitivity and insulin resistance after the conversion from tacrolimus twice daily to extended-release tacrolimus once daily in stable renal transplant recipientsinsulin sensitivityinsulin resistanceinsulin sensitivitytacrolimusextended release tacrolimus once dailyinsulin resistanceTCTR20151005001Prajej Ruangkanchanasetr28
招募中
不适用
The change in organ specific insulin sensitivity after treatment of endocrine and metabolic disorderendocrine and metabolic disorderJPRN-UMIN000033791Kanazawa university hospital Department of Endocrinology and metabolism100
已完成
不适用
Effects for glucose metabolism, body composition, and circulatory dynamics of SGLT2 inhibitorType 2 diabetes mellitusJPRN-UMIN000017195Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki30
已完成
不适用
A Novel Diet-Phenotype Interaction Affecting Body WeightMetabolic SyndromeObesityNCT01303757Boston Children's Hospital155